# Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer

> **NCT02577588** · PHASE1 · TERMINATED · sponsor: **National Center for Tumor Diseases, Heidelberg** · enrollment: 1 (actual)

## Conditions studied

- Colorectal Carcinoma

## Interventions

- **BIOLOGICAL:** re-activated T cells

## Key facts

- **NCT ID:** NCT02577588
- **Lead sponsor:** National Center for Tumor Diseases, Heidelberg
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05-01
- **Primary completion:** 2018-02-19
- **Final completion:** 2018-02-19
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** not feasible
- **Last updated:** 2018-04-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02577588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02577588, "Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT02577588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*